Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3841) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency recommends authorisation of additional vaccine for influenza pandemic (H1N1) 2009 2 Οκτώβριος 2009Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 September 2009 25 Σεπτέμβριος 2009Press releaseHuman Supply shortage of Fabrazyme – updated treatment recommendations required for adult male patients 25 Σεπτέμβριος 2009Press release European Medicines Agency recommends authorisation of two vaccines for influenza pandemic (H1N1) 2009 25 Σεπτέμβριος 2009Press releaseMedicines Meeting highlights from the Paediatric Committee: 16 - 18 September 2009 24 Σεπτέμβριος 2009Press releaseHumanPaediatrics CTI Life Sciences Ltd. withdraws its marketing authorisation application for Opaxio (paclitaxel poliglumex) 23 Σεπτέμβριος 2009Press release Committee for medicinal products for veterinary use: Meeting of 15-17 September 2009 18 Σεπτέμβριος 2009Press releaseVeterinary The bacterial challenge - Time to react a call to narrow the gap between multidrug-resistant bacteria in the EU and development of new antibacterial agents 17 Σεπτέμβριος 2009Press release Sanofi-Aventis withdraws marketing authorisation application for MULTAQ 8 Σεπτέμβριος 2009Press release Meeting highlights from the Paediatric Committee held by written procedure: 19 - 21 August 2009 25 Αύγουστος 2009Press releaseHumanPaediatrics 1 … 299 300 301 302 303 Page 303 of 385 304 305 306 307 … 385
European Medicines Agency recommends authorisation of additional vaccine for influenza pandemic (H1N1) 2009 2 Οκτώβριος 2009Press releaseMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 September 2009 25 Σεπτέμβριος 2009Press releaseHuman
Supply shortage of Fabrazyme – updated treatment recommendations required for adult male patients 25 Σεπτέμβριος 2009Press release
European Medicines Agency recommends authorisation of two vaccines for influenza pandemic (H1N1) 2009 25 Σεπτέμβριος 2009Press releaseMedicines
Meeting highlights from the Paediatric Committee: 16 - 18 September 2009 24 Σεπτέμβριος 2009Press releaseHumanPaediatrics
CTI Life Sciences Ltd. withdraws its marketing authorisation application for Opaxio (paclitaxel poliglumex) 23 Σεπτέμβριος 2009Press release
Committee for medicinal products for veterinary use: Meeting of 15-17 September 2009 18 Σεπτέμβριος 2009Press releaseVeterinary
The bacterial challenge - Time to react a call to narrow the gap between multidrug-resistant bacteria in the EU and development of new antibacterial agents 17 Σεπτέμβριος 2009Press release
Sanofi-Aventis withdraws marketing authorisation application for MULTAQ 8 Σεπτέμβριος 2009Press release
Meeting highlights from the Paediatric Committee held by written procedure: 19 - 21 August 2009 25 Αύγουστος 2009Press releaseHumanPaediatrics